Recombinant 10 kDa chaperonin (groS)

Shipped with Ice Packs
In Stock

Description

Structure and Function

GroS forms a heptameric ring structure (7 subunits) with a molecular weight of ~10 kDa per monomer. It binds to the apical domain of GroEL, a 14-subunit cylinder, creating a nano-cage that facilitates protein folding by encapsulating substrate proteins. This interaction inhibits GroEL’s ATPase activity by 40–60% at a 2:1 molar ratio (GroS:GroEL), ensuring substrates remain protected until properly folded .

FeatureDetail
Subunits7 identical 10 kDa subunits
Binding PartnerGroEL (Chaperonin 60)
ATPase Inhibition40–60% at 2:1 ratio (GroS:GroEL)
FunctionCo-chaperone for nascent or denatured proteins

Production and Purification

Recombinant groS is expressed in various hosts:

  • E. coli: High-yield production with >95% purity (Abcam , Cusabio ).

  • Yeast/Mammalian Cells: Used for post-translational modifications (Lifeome , Cusabio ).

  • Baculovirus: Produces biologically active forms (Cusabio ).

Purification involves conventional chromatography (ProspecBio ) or gel filtration (Sigma-Aldrich ).

Research Applications

GroS is critical for studying protein folding in vitro. Key examples include:

  • Refolding Assays: Reactivates enzymes like rhodanese and RuBisCO .

  • Immune Modulation: Recombinant groS (as EPF/cpn10) suppresses autoimmune encephalomyelitis (EAE) by reducing inflammation and promoting oligodendrocyte survival .

  • Cancer Research: Overexpression in tumors suggests potential as a tumor marker .

Clinical Implications

GroS homologs (e.g., Hsp10 in humans) show promise in treating autoimmune diseases. Studies demonstrate:

  • Multiple Sclerosis: Recombinant Hsp10 reduces pro-inflammatory cytokines and improves EAE outcomes .

  • Early Pregnancy Factor (EPF): Detectable in maternal serum within 6–72 hours post-conception, aiding infertility diagnostics .

Key Research Highlights

StudyFindings
Protein Folding GroS enhances GroEL-mediated refolding of denatured rhodanese by 2-fold
Autoimmune Diseases Recombinant Hsp10 inhibits TLR signaling and reduces EAE severity
Pregnancy Biomarker EPF detection correlates with early embryonic viability in humans and animals

Product Specs

Form
Lyophilized powder. We will ship the in-stock format preferentially. If you have specific format requirements, please note them when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult your local distributor for specifics. All proteins are shipped with standard blue ice packs. Requesting dry ice will incur extra fees; please communicate this in advance.
Notes
Avoid repeated freezing and thawing. Working aliquots are stable at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Adding 5-50% glycerol (final concentration) is recommended for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer composition, temperature, and protein stability. Liquid form is generally stable for 6 months at -20°C/-80°C. Lyophilized form is generally stable for 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon arrival. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. Please inform us if you require a specific tag, and we will prioritize its development.
Synonyms
groS; groES; mopB10 kDa chaperonin; GroES protein; Protein Cpn10
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-96
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Holospora obtusa
Target Names
groS
Target Protein Sequence
MTKFKPLGDR ILVKRVEAEE RTSGGIVIPD TAKEKPIEGT VIAVGPGARD PQGNLIALEV KQGDRVLFGK WSGTEVKLSG EDYIVMKESD VFGTIA
Uniprot No.

Target Background

Function
GroS, along with GroEL, plays a crucial role in protein folding. The GroEL-GroES system creates a nano-cage, encapsulating non-native proteins to provide an environment that optimizes and accelerates protein folding. GroES binds to GroEL's apical surface, capping the GroEL channel opening.
Protein Families
GroES chaperonin family
Subcellular Location
Cytoplasm.

Q&A

What is recombinant 10 kDa chaperonin (GroES) and what are its alternative nomenclatures?

Recombinant 10 kDa chaperonin (GroES) is a molecular chaperone protein crucial for efficient protein folding under both normal and stress conditions. It is alternatively known as CPN10, HSP10, HSPE1, Chaperonin-10, 10 kDa heat shock protein mitochondrial, 10 kDa chaperonin, and Early-pregnancy factor (EPF) . The recombinant form is typically produced in expression systems such as Escherichia coli and contains 102 amino acids with a molecular mass of 10 kDa . Understanding the various nomenclatures is essential when conducting comprehensive literature reviews to ensure you capture all relevant research using different terminology.

What is the functional mechanism of GroES in protein folding?

GroES functions primarily through its interaction with HSP60 (GroEL) in an ATP-dependent manner. The molecular mechanism involves:

  • GroES binding to HSP60 in the presence of ATP

  • This binding induces a conformational change in HSP60

  • The conformational change creates an enclosed environment for the substrate protein

  • ATP hydrolysis by chaperonin-60 (HSP60) destabilizes the HSP10-HSP60 complex

  • Destabilization allows the complex to dissociate and release the properly folded substrate protein

This mechanism is fundamental to preventing protein aggregation and misfolding, particularly under cellular stress conditions. Research approaches typically investigate this process using structural biology techniques and functional assays measuring ATP hydrolysis and protein folding efficiency.

How should I design experiments to study GroES-mediated protein folding?

When designing experiments to study GroES-mediated protein folding, follow these methodological steps:

  • Define your variables:

    • Independent variable: Typically GroES concentration or mutations

    • Dependent variable: Protein folding efficiency or chaperone activity

    • Control variables: Temperature, pH, ATP concentration

  • Formulate a testable hypothesis: For example, "Specific mutations in the GroES binding interface will reduce its ability to facilitate protein folding by X%"

  • Establish experimental treatments:

    • Include wild-type GroES (positive control)

    • Include no GroES (negative control)

    • Include various GroES concentrations or mutant forms

  • Apply randomized block design: Group experiments by protein substrate types and randomly assign treatments within these groups to minimize bias

  • Measure outcomes using established folding assays such as:

    • Circular dichroism spectroscopy

    • Fluorescence-based assays

    • ATPase activity measurements

    • Aggregation prevention assays

This systematic approach allows for rigorous testing of GroES function while controlling for confounding variables that might influence protein folding outcomes .

What are the optimal storage conditions for recombinant GroES to maintain activity?

For optimal storage of recombinant GroES while maintaining biological activity, follow these evidence-based guidelines:

Storage DurationTemperatureAdditivesAdditional Recommendations
Short-term (2-4 weeks)4°COriginal buffer (20mM Tris buffer pH-8 & 50mM NaCl)Use sterile containers
Long-term (>1 month)-20°CAdd carrier protein (0.1% HSA or BSA)Avoid multiple freeze-thaw cycles
Extended archival-80°CAdd carrier protein and 10% glycerolAliquot in single-use volumes

The addition of carrier proteins such as human serum albumin (HSA) or bovine serum albumin (BSA) at 0.1% concentration is particularly important for long-term storage as it prevents protein adsorption to container surfaces and increases stability . When designing experiments, incorporate activity assays after storage to verify that the protein maintains its functional properties before use in critical experiments.

How can I validate the purity and functionality of recombinant GroES preparations?

To validate recombinant GroES preparations for research applications, implement a multi-method verification approach:

  • Purity Assessment:

    • SDS-PAGE analysis (expect >95% purity)

    • Size exclusion chromatography to confirm monodispersity

    • Mass spectrometry to verify molecular weight and sequence integrity

  • Structural Validation:

    • Circular dichroism to confirm secondary structure

    • Dynamic light scattering to assess aggregation state

    • Thermal shift assays to determine stability

  • Functional Verification:

    • ATP-dependent binding to GroEL using pull-down assays

    • Co-chaperone activity in protein refolding assays with model substrates

    • ATPase activity stimulation in the presence of GroEL

  • Documentation:

    • Maintain detailed records of validation results

    • Compare results to established quality benchmarks

    • Document batch-to-batch variation

This comprehensive validation strategy ensures that experimental observations can be confidently attributed to GroES activity rather than contaminants or non-functional protein species. Experimental replicates should use the same validated batch when possible, or include careful cross-batch validation.

How can I design GroES mutations to study structure-function relationships?

Designing targeted GroES mutations requires a systematic approach to interrogate specific structural features and their relationship to function:

  • Structure-based design strategy:

    • Analyze high-resolution crystal structures of GroES-GroEL complexes

    • Identify key residues at protein-protein interfaces

    • Target conserved residues across species for evolutionary significance

    • Use molecular dynamics simulations to predict effects of mutations

  • Types of mutations to consider:

    • Alanine scanning: Replace specific residues with alanine to eliminate side chain interactions

    • Conservative substitutions: Maintain similar properties (e.g., Asp→Glu)

    • Non-conservative substitutions: Dramatically alter properties (e.g., Lys→Glu)

    • Domain swapping: Replace entire domains with corresponding regions from related proteins

  • Mutational analysis workflow:

    • Generate mutations using site-directed mutagenesis

    • Express and purify mutant proteins using identical protocols to wild-type

    • Verify structural integrity using circular dichroism or thermal stability assays

    • Perform comparative functional assays alongside wild-type controls

  • Functional assays to consider:

    • GroEL binding affinity measurements

    • ATP hydrolysis modulation

    • Substrate protein folding efficiency

    • Temperature sensitivity profiles

This methodical approach allows researchers to establish direct links between specific structural elements and functional outcomes, contributing to our understanding of GroES mechanism of action.

What approaches can be used to study the interaction between GroES and GroEL under different conditions?

Studying GroES-GroEL interactions across varying conditions requires multiple complementary techniques:

  • Biophysical interaction methods:

    • Surface plasmon resonance (SPR) to measure real-time binding kinetics

    • Isothermal titration calorimetry (ITC) for thermodynamic parameters

    • Analytical ultracentrifugation to measure complex formation

    • FRET-based assays using fluorescently labeled proteins

  • Structural determination approaches:

    • Cryo-electron microscopy for visualizing different conformational states

    • X-ray crystallography for atomic-level details at specific states

    • Hydrogen-deuterium exchange mass spectrometry to map interaction interfaces

  • Condition variables to investigate:

    • Temperature ranges (physiological vs. stress conditions)

    • pH variations (cytoplasmic vs. compartmentalized environments)

    • Nucleotide states (ATP, ADP, non-hydrolyzable analogs)

    • Salt concentrations and ionic strength

    • Presence of substrate proteins or competing factors

  • Data integration framework:

    • Develop mathematical models of the interaction cycle

    • Correlate structural changes with functional outcomes

    • Map energetic landscapes across different conditions

This multi-technique approach provides a comprehensive understanding of how environmental factors influence the GroES-GroEL chaperonin system, revealing mechanisms that may be exploited in biotechnological applications or therapeutic interventions.

How can systems biology approaches be applied to understand GroES function in cellular contexts?

Systems biology approaches offer powerful frameworks for understanding GroES function within the broader cellular context:

  • Network analysis methodologies:

    • Construct protein-protein interaction networks centered on GroES

    • Identify hub proteins that interact with multiple chaperone system components

    • Map chaperone dependencies using correlation analyses across different stress conditions

    • Integrate transcriptomic and proteomic data to identify co-regulated systems

  • Multi-omics integration strategies:

    • Combine proteomics data on GroES interactors

    • Correlate with transcriptomics under stress conditions

    • Integrate metabolomics to identify effects on cellular energetics

    • Use phosphoproteomics to detect signaling events affecting chaperone function

  • Computational modeling approaches:

    • Develop ordinary differential equation models of chaperone cycling

    • Create agent-based models of spatial chaperone distribution

    • Implement machine learning to predict substrate specificities

    • Use flux balance analysis to understand metabolic impacts

  • Experimental validation methods:

    • CRISPR-mediated gene editing to create cellular models

    • Synthetic genetic array analysis to map genetic interactions

    • Live-cell imaging to track chaperone dynamics

    • Ribosome profiling to identify co-translational folding dependencies

This integrated systems approach reveals emergent properties of GroES function that cannot be identified through reductionist experiments alone, providing insights into complex cellular adaptations to proteostatic challenges.

How should researchers address contradictory results in GroES functional studies?

When encountering contradictory results in GroES functional studies, apply this systematic troubleshooting framework:

  • Methodological analysis:

    • Compare experimental conditions in detail (buffer compositions, temperatures, incubation times)

    • Evaluate protein preparation methods (expression systems, purification protocols, storage conditions)

    • Assess assay sensitivity and specificity (positive/negative controls, signal-to-noise ratios)

    • Review reagent quality (age of preparations, batch variations, potential contaminants)

  • Literature-based reconciliation:

    • Perform systematic literature reviews to identify patterns in contradictory findings

    • Contact authors of conflicting studies for clarification on undocumented methodological details

    • Evaluate whether differences reflect biological diversity or experimental artifacts

  • Resolution experiments:

    • Design experiments specifically to address the contradiction

    • Include side-by-side comparisons of methods from conflicting studies

    • Introduce additional controls to isolate variables causing discrepancies

    • Consider blind analysis to minimize unconscious bias in data interpretation

  • Statistical approaches:

    • Increase sample sizes to enhance statistical power

    • Use appropriate statistical tests based on data distribution

    • Consider meta-analysis approaches when applicable

    • Report effect sizes alongside statistical significance

This structured approach helps distinguish genuine biological complexity from technical artifacts, advancing the field's understanding of GroES function while maintaining scientific rigor.

What statistical approaches are most appropriate for analyzing GroES activity data?

Selecting appropriate statistical methods for GroES activity data requires careful consideration of experimental design and data characteristics:

Data TypeRecommended Statistical ApproachesConsiderations
Enzyme kineticsNon-linear regression, Michaelis-Menten analysisTest goodness-of-fit using residual plots
Binding assaysScatchard analysis, Hill plotsAccount for cooperativity and multiple binding sites
Comparative activityANOVA with post-hoc tests (Tukey, Bonferroni)Verify assumptions of normality and homogeneity of variance
Concentration-responseEC50/IC50 determination, four-parameter logistic modelAppropriate for dose-response relationships
Time-course dataRepeated measures ANOVA, mixed-effects modelsAccounts for non-independence of measurements
Thermal stabilityBoltzmann sigmoidal fittingFor thermal denaturation curves

When designing experiments, consider:

  • Power analysis to determine appropriate sample sizes

  • Randomization within experimental blocks to minimize bias

  • Blinding analysis when possible

  • Including technical and biological replicates

For complex datasets, advanced approaches such as principal component analysis or machine learning algorithms may reveal patterns not apparent with traditional statistical methods. Always report both statistical significance and effect sizes, as small p-values don't necessarily indicate biologically meaningful differences.

How can researchers optimize expression and purification of recombinant GroES for structural studies?

Optimizing recombinant GroES expression and purification for structural studies requires attention to multiple factors:

  • Expression system optimization:

    • Compare E. coli strains (BL21(DE3), Rosetta, SHuffle) for optimal expression

    • Test induction conditions (temperature, IPTG concentration, induction time)

    • Evaluate different promoter systems (T7, tac, araBAD)

    • Consider codon optimization based on expression host

  • Fusion tag selection:

    • His-tag for IMAC purification (minimal size impact)

    • GST-tag for improved solubility (but larger size)

    • SUMO or MBP tags for enhanced folding and solubility

    • Include precision protease cleavage sites for tag removal

  • Purification strategy development:

    • Multi-step chromatography approach:

      1. Affinity chromatography (IMAC, GST)

      2. Ion exchange chromatography

      3. Size exclusion chromatography

    • Optimize buffer conditions for each step (pH, salt, additives)

    • Implement quality control checkpoints (SDS-PAGE, activity assays)

  • Structural quality considerations:

    • Final buffer optimization for structural techniques

    • Concentration protocols that minimize aggregation

    • Homogeneity verification via dynamic light scattering

    • Thermal stability assessment via differential scanning fluorimetry

Following purification, GroES should achieve >95% purity as determined by SDS-PAGE and demonstrate uniform size distribution by size exclusion chromatography. For crystallography studies, additional considerations include buffer screening for crystal formation and cryoprotectant selection.

What are the emerging research directions in GroES chaperonin studies?

Current literature indicates several promising research directions in GroES chaperonin studies:

  • Structural biology advancements:

    • Application of cryo-electron microscopy to capture transient conformational states

    • Time-resolved structural studies of the complete chaperonin cycle

    • Integration of computational approaches with experimental structural data

  • Systems-level understanding:

    • Mapping the complete "chaperome" network interactions

    • Elucidating differential substrate specificities under various stress conditions

    • Understanding co-chaperone interplay in complex cellular environments

  • Therapeutic applications:

    • Development of small molecule modulators of chaperonin function

    • Exploitation of chaperonin systems for protein folding diseases

    • Engineering modified chaperonins with enhanced specificity or activity

  • Biotechnological innovations:

    • Designer chaperonins for difficult-to-express proteins

    • Incorporation into cell-free protein synthesis systems

    • Application in protein stabilization for biopharmaceuticals

These emerging directions highlight the continuing importance of fundamental research on GroES structure and function, with potential applications spanning from basic molecular understanding to clinical interventions for protein misfolding disorders.

How can researchers best present GroES research findings in publications?

Effective presentation of GroES research findings requires thoughtful organization of both textual and visual elements:

  • Data visualization best practices:

    • Use clear, informative figures showing key structural features and functional relationships

    • Present comparative data in well-structured tables rather than lists

    • Design figures that stand alone with comprehensive legends

    • Include molecular visualizations with proper structural representations

  • Results organization strategy:

    • Begin with participant/sample characteristics (first table)

    • Present associations/comparisons between variables progressively

    • Show raw data before adjusted models

    • Include appropriate statistical analyses with effect sizes

  • Technical communication approaches:

    • Use topic sentences to guide readers through logical progression

    • Define specialized terminology and abbreviations at first use

    • Cite sources inline rather than as URLs

    • Reserve bold formatting only for critical terms or findings

  • Publication enhancement tactics:

    • Consider supplementary materials for detailed methodological information

    • Provide code and datasets in repositories for reproducibility

    • Create graphical abstracts summarizing key findings

    • Include video abstracts for complex methodologies

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.